Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Complement Med Res ; 28(4): 300-307, 2021.
Article in English | MEDLINE | ID: covidwho-975758

ABSTRACT

BACKGROUND: Vitamin D has been shown to be associated with reduced risk and severity of COVID-19 and exerts regulating effects on all hallmarks of cancer. The goal of this study was to analyze the vitamin D status of a cancer patient cohort from our clinic in the Franconian region, Germany. METHODS: 25-hydroxyvitamin D concentrations were available for 116 patients included in prospective trials in our clinic. Associations of vitamin D with anthropometric and blood parameters were investigated using Kendall's τ correlation coefficients and linear regression. RESULTS: A total of 57 patients (49.1%) were vitamin D deficient (<20 ng/mL), and 92.2% did not meet the recommended vitamin D level of 40 ng/mL. There was a strong negative association between vitamin D and leukocyte count (τ = -0.173, p = 0.007) and C-reactive protein concentration (τ = -0.172, p = 0.007). In linear regression, the most important variables for predicting vitamin D levels were (in order of decreasing importance) season, fat mass index, platelet, and leukocyte count. CONCLUSIONS: Despite appeals towards medical societies to target widespread vitamin D deficiency in Germany more than 10 years ago, our data indicate that these have been without avail. Low vitamin D levels in cancer patients should be corrected using reasonable sun exposure and supplements.


Subject(s)
COVID-19/complications , Neoplasms/radiotherapy , Vitamin D Deficiency/complications , Vitamin D/blood , Adult , Aged , C-Reactive Protein/analysis , COVID-19/blood , COVID-19/mortality , COVID-19/virology , Dietary Supplements , Female , Humans , Male , Middle Aged , Neoplasms/blood , Prospective Studies , SARS-CoV-2 , Vitamin D/analogs & derivatives , Vitamin D Deficiency/blood
2.
Med Oncol ; 37(9): 76, 2020 Aug 01.
Article in English | MEDLINE | ID: covidwho-691683

ABSTRACT

We here express our concern about a general decree to let patients wear face masks in radiation oncology clinics. We believe that potential risks associated with wearing masks, such as the risk of confounding patients, outweigh any benefits of such a policy for which evidence of protection from COVID-19 is generally weak. For asymptomatic patients, wearing masks in addition to hygiene standards will not provide additional protection of others and should be cautioned against.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/epidemiology , Evidence-Based Medicine , Masks/statistics & numerical data , Masks/standards , Pneumonia, Viral/epidemiology , Radiation Oncology/standards , Radiotherapy Setup Errors/prevention & control , COVID-19 , Coronavirus Infections/transmission , Coronavirus Infections/virology , Humans , Pandemics , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL